ViewPoint Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 12, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $35,000,000
Company Info
- Founding Year
- 2014
- Founders
- Dr. Jason Gestwicki, Dr. Usha Andley
- Company Description
- ViewPoint is a preclinical-stage biotechnology company passionately committed to the discovery, development, and commercialization of treatments for diseases of protein misfolding, which is implicated in numerous common disorders of aging including cataracts and presbyopia.
- Market
- Diseases of protein misfolding
- Location
- San Francisco, California, USA
- Coinvestors
- Biotechnology Value Fund, Lagunita, Mission Bay Capital, Novo Holdings, The Rise Fund, University of Michigan